The global prefilled syringe market is anticipated to grow at a considerable CAGR of around 9.5% during the forecast period. Increase in innovations in prefilled products for biological drugs isaugmenting the prefilled syringes market growth. The rising demand for biological drugs, and growing innovations in injectable delivery solutions are creating significant scope for the market growth. Moreover, biological drugs currently attracted the attention of leading players as they target diseases that had no or very limited treatment options available. Moreover, the rising number of patients utilizing biologics as a cure selection for prolonged illnesses and robust implementation of progressive distribution approaches for self-injection of medications, hence boosting the market. For instance, in October 2021, BD and Aptar Pharma in partnership launched a Plunger stopper to support biologic drugs with high viscosity formulations. BD SCF PremiumCoat is a syringe plunger stopper that is designed to support the injection of biologics into subcutaneous tissue with a 1mlL pre-filled syringe. 

The lack of prefilled syringes with integrated safety features is hampering the growth of the prefilled syringes market. Growing healthcare infrastructure across emerging economies as they suffer from insufficient health care funding, that adversly affects access to healthcare, quality, and, ultimately, the health status of citizens. According to the Global Burden of Diseases Health Financing collaborator network in 2017 estimated that spending on health will triple to USD 24 trillion by 2040 with upper middle-income countries, this is expected to drive the demand for  prefilled syringe in healthcare sector during the forecast period.

Impact of COVID-19 Pandemic on Global Prefilled Syringe Market

The impact of COVID-19 was positive on the prefilled syringes market, due to the rapid production of vaccines for the COVID-19 there was an increase in demand for such syringes over glass ampoules and needles because of the reduced risk of needle stick injuries. The key manufacturers were rapidly increasing the production capacity of the COVID-19 vaccine. For instance, in May 2020, the Department of Defense and the U.S. Department of Health and Human Services has signed a contract of $138 million with  ApiJect Systems America for a new "Project Jumpster" and "RAPID USA".  Both in coordination with HHS Office of the Assistant Secretary for Preparedness and Response will support "Jumpstart" to create the US-based, high-speed supply chain for prefilled syringes.

Segmental Outlook 

The global prefilled syringe market is segmented based on the material, design, and application. Based on the material, the market is segmented into glass-based, and plastic-based.Based on the design, the market is segmented into a single chamber, double chamber and customize. On the basis of application, the market is sub-segmented into arthritis, anaphylaxis, ophthalmology, diabetes, cancer, and others. Among the design segment,double chamber sub-segment is dominating owing to the growing technological innovations and shifts in preference from single chamber to double chamber system.

Double chamber prefilled syringes are highly efficient for storing biological components which cannot retain their stability for a long period also the increase in penetration of lyophilized drugs globally will raise the demand for double-chambered syringes.

Global Prefilled Syringe  Market Share by Product Type, 2020 (%)

The Glass Based Segment Holds the Major Share in the Global Prefilled Syringe Market

Glass-based prefilled syringe segment is dominating attributed to the factor such as the strong barrier property of the glass. It is the highly preferred material for manufacturing and also it is highly compatible with various filling drug machines. These syringes are also greater than plastic syringes due to being highly used by healthcare professionals and they are easy to use and lower the risk at the time of injection. Moreover, due to the increase in adoption of prefilled syringes in the developing regions, where glass syringes provide reusability and lower cost the glass-based syringes market will grow. Additionally, the pharmaceutical industry  uses glass-based syringes manufactured from type 1 borosilicate glass, that consists of silicon dioxide, along with oxides of boron, aluminum, sodium, and potassium. It also consists of metal ions, specifically sodium dioxide, and is included in the mixture. For instance, In March 2019, SCHOTT launched syriQ BioPure® lubricant-free – the first Prefillable glass syringe (PFS) that eliminates the need for silicone or similar substances.

Regional Outlooks

The global prefilled syringe market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East &Africa, and Latin America).. Europe is dominating the global prefilled syringe market due to the high adoption of self-injection devices are driving the demand for self-injectable prefilled syringes. Apart from this, high prevalence of chronic diseases, technological advancements and presence of prominent players are also  the major factors driving the growth of the prefilled syringes market in Europe. 

Global Prefilled Syringe  Market Growth, by Region 2021-2027

The Asia-Pacific Region is Estimated to be the Fastest Growing in the Global Prefilled Syringe Market

The Asia-Pacific displayed fastest growth in the market in 2020. And it is further estimated to be the fastest growing region during the forecast period owing to the rising prevalence of chronic diseases, rise in usage of prefilledsyringes, and rapidly growing patient population across the region. Additionally, the increasing awareness regarding innovations in these syringes and growing contact in manufacturing companies outsourcing packaging and filling services are boosting the prefilled syringes market growth in the region. For instance, in October 2021, West Pharmaceutical Service launched its latest offering for India, NovaGuard SA Pro Safety System, a single-use accessory for prefilled ISO standard 0.5mL staked needle syringes.

Market Players Outlook

The major companies serving the global prefilled syringe market include Becton, Dickinson and Co., Baxter International, Inc., Gerresheimer AG, Pfizer Inc., SCHOTT AG, Terumo Corp., Teva Pharmaceutical Industries Ltd., Ypsomed AG, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in December 2020, Becton, Dickinson, and Co. have invested approximately $1.2 billion over 4 years to expand manufacturing capacity and technology for pre-fillable syringes (PFS) and advanced drug delivery systems (ADDS) across its six global manufacturing locations. The companyalso added a new manufacturing facility in Europe. Moreover, the investment will also fund capacity, new product innovations, manufacturing technology enhancements, and business continuity improvements across all the global locations.

The Report Covers

• Market value data analysis of 2020 and forecast to 2027.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global prefilled syringe market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market.